ESR1 and breast carcinoma: We previously showed that ERα-positive breast cancer cells (MCF-7, CAMA, and T47D) grown under hypoxic conditions were resistant to antiestrogens (tamoxifen and fulvestrant), while they were sensitive to treatment at normoxia, and treating the resistant hypoxic cancer cells with a HIF-inhibitor (FM19G11) restored antiestrogen sensitivity [15].